Levlen is an oral contraceptive that combines an estrogen and a progestin to prevent pregnancy. It works by suppressing ovulation through hormonal feedback mechanisms. The estrogen component stabilizes the endometrium and reduces the risk of breakthrough bleeding. The progestin inhibits sperm penetration and alters cervical mucus to create a barrier to fertilization. Together these hormones modulate the hypothalamic-pituitary-gonadal axis to maintain consistent contraceptive efficacy. The active ingredients influence uterine blood flow and cervical secretions to support an environment unfavorable to implantation. By delivering a steady low dose of both hormones the medication provides reliable birth control through these coordinated physiological actions.

Levlen is a combined oral contraceptive that contains an estrogen and a progestin component. The estrogen portion suppresses the hypothalamic-pituitary axis to reduce follicular development and ovulation. The progestin ingredient thickens cervical mucus to impede sperm penetration and alters the endometrium to prevent implantation. Together these actions provide reliable birth control by preventing conception without affecting sexual function. Levlen's pharmacodynamics rely on steady hormone levels that maintain these contraceptive effects throughout the cycle. The medication is absorbed orally, reaches peak plasma concentrations within hours, and is metabolized primarily by the liver before elimination. Its consistent dosing schedule ensures predictable hormonal exposure and maximal contraceptive efficacy.

Levlen may cause nausea, especially during the first few weeks of use. It can lead to breast tenderness or enlargement. Some users experience irregular spotting between menstrual cycles. Headaches or dizziness may occur, particularly when starting the medication. Weight fluctuations are possible but not common. Mood changes such as irritability or mild depression have been reported. Less frequently, it may increase the risk of blood clots, though this risk is generally low.

Levlen may cause nausea in some users. Headaches are a reported side effect of the medication. Breast tenderness can occur during the initial weeks of use. Spotting between periods is sometimes observed. Mood changes have been documented in certain users. Weight fluctuations are occasionally associated with oral contraceptive use. Changes in libido are reported in a small subset of individuals.